Skip to main content
NIH funding notice RFA-RM-22-006

Expert-Driven Small Projects to Strengthen Gabriella Miller Kids First Discovery (R03 Clinical Trial Not Allowed)

Closed on June 10, 2022.

Posted
November 17, 2021
Close date
June 10, 2022
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

3 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $494,750 in first-year total cost, median $169,000.

Most frequent study sections

  1. Special Emphasis Panel[ZRG1 IMST-J (70)]3

Most frequent institutions

  1. ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI1
  2. UNIVERSITY OF CONNECTICUT STORRS1
  3. UNIVERSITY OF TEXAS HLTH SCIENCE CENTER1
Competing awards under RFA-RM-22-006 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2023Structural Variation analysis of Orofacial Cleft associated genomic regions in African and Asian populations1R03DE033083-01BAYARSAIHAN, DASHZEVEGBECKER, TIMOTHY JAMESSHIN, DONG-GUKUNIVERSITY OF CONNECTICUT STORRS, CT$170,750ZRG1
2023Bayesian genetic association analysis of all rare diseases in the Kids First cohort1R03HD111492-01TURRO, ERNESTICAHN SCHOOL OF MEDICINE AT MOUNT SINAI, NY$169,000ZRG1
2023Chromosome 18 Cohort Phenotype Enrichment to Strengthen the Gabriella Miller Kids First Program1R03HD111405-01CODY, JANNINE DE MARSUNIVERSITY OF TEXAS HLTH SCIENCE CENTER, TX$155,000ZRG1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.